Moderna, 29 weeks in: residual capital at +170% with a trailing stop

Moderna is in week 29 of a buy trade that has already completed the model's coverage: all 3 statistical references were hit in the early weeks, and the residual, untrimmed capital now runs at +170.74% since entry. The stop trails the Inversion Point, in the 62.9 area, protecting the accumulated gain. On the technical side, the week just closed shows acceleration, not a slowdown.